Simplex Trading
NYMX

Simplex Trading’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Simplex Trading’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,000
Closed -$10K – 10563
2022
Q4 		$10K Buy
36,000
+17,300
+93% +$6.26K ﹤0.01% 7595
2022
Q3 		$7K Buy
18,700
+15,100
+419% +$6K ﹤0.01% 8596
2022
Q2 		$1K Sell
3,600
-1,800
-33% -$1.66K ﹤0.01% 9768
2022
Q1 		$6K Sell
5,400
-400
-7% -$618 ﹤0.01% 9363
2021
Q4 		$7K Buy
5,800
+1,100
+23% +$1.75K ﹤0.01% 9366
2021
Q3 		$7K Hold
4,700
– – ﹤0.01% 9160
2021
Q2 		$7K Buy
4,700
+4,654
+10,117% +$8.63K ﹤0.01% 9328
2021
Q1 		$10K Sell
46
-64
-58% -$169 ﹤0.01% 7914
2020
Q4 		$27K Buy
110
+48
+77% +$106 ﹤0.01% 6766
2020
Q3 		$15K Sell
62
-539
-90% -$1.57K ﹤0.01% 6584
2020
Q2 		$213K Buy
601
+537
+839% +$1.7K ﹤0.01% 3926
2020
Q1 		$14K Hold
64
– – ﹤0.01% 6255
2019
Q4 		$14K Sell
64
-8
-11% -$16 ﹤0.01% 6215
2019
Q3 		$13K Buy
72
+40
+125% +$70 ﹤0.01% 6118
2019
Q2 		$4K Sell
32
-165
-84% -$289 ﹤0.01% 6581
2019
Q1 		$38K Sell
197
-144
-42% -$305 ﹤0.01% 5232
2018
Q4 		$44K Buy
341
+86
+34% +$157 ﹤0.01% 4647
2018
Q3 		$62K Sell
255
-78
-23% -$230 ﹤0.01% 4959
2018
Q2 		$111K Sell
333
-559
-63% -$2.15K ﹤0.01% 4175
2018
Q1 		$61K Buy
892
+664
+291% +$2.3K ﹤0.01% 2247
2017
Q4 		$2K Sell
228
-243
-52% -$886 ﹤0.01% 5305
2017
Q3 		$3K Sell
471
-31
-6% -$118 ﹤0.01% 4903
2017
Q2 		$60K Buy
502
+32
+7% +$131 ﹤0.01% 2225
2017
Q1 		$41K Buy
470
+240
+104% +$790 ﹤0.01% 2565
2016
Q4 		$10K Buy
230
+68
+42% +$211 ﹤0.01% 3774
2016
Q3 		$19K Buy
162
+76
+88% +$249 ﹤0.01% 3043
2016
Q2 		$8K Sell
86
-168
-66% -$413 ﹤0.01% 3854
2016
Q1 		$11K Buy
+254
New +$601 ﹤0.01% 3408
2015
Q4 		– Sell
-40
Closed -$4K – 6340
2015
Q3 		$4K Buy
+40
New +$93 ﹤0.01% 4231

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
CF
Corrigan Financial Middletown, Rhode Island $485M AUM 4.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's NYMX Position: Q4 2022 in Review

Simplex Trading sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2022, closing a stake of 1,113 shares — an estimated $403 sold.

Simplex Trading first reported a position in NYMX in Q3 2015 and held it in 23 quarters. The position peaked at $295K in Q3 2018. 37 funds tracked by Wall St. Rank hold NYMX as of Q4 2022.

  • Simplex Trading reported no remaining Nymox Pharmaceutical Corp position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 1,113 Nymox Pharmaceutical Corp shares in Q4 2022, an estimated $403.
  • Simplex Trading first reported a position in Nymox Pharmaceutical Corp in Q3 2015 and held it in 23 quarters.
  • Simplex Trading's Nymox Pharmaceutical Corp position peaked at $295K in Q3 2018.
  • 37 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.